These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18477668)

  • 1. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.
    Trivedi RN; Wang XH; Jelezcova E; Goellner EM; Tang JB; Sobol RW
    Mol Pharmacol; 2008 Aug; 74(2):505-16. PubMed ID: 18477668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
    Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW
    Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.
    Trivedi RN; Almeida KH; Fornsaglio JL; Schamus S; Sobol RW
    Cancer Res; 2005 Jul; 65(14):6394-400. PubMed ID: 16024643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.
    Goellner EM; Grimme B; Brown AR; Lin YC; Wang XH; Sugrue KF; Mitchell L; Trivedi RN; Tang JB; Sobol RW
    Cancer Res; 2011 Mar; 71(6):2308-17. PubMed ID: 21406402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells.
    Rinne M; Caldwell D; Kelley MR
    Mol Cancer Ther; 2004 Aug; 3(8):955-67. PubMed ID: 15299078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.
    Stachelek GC; Dalal S; Donigan KA; Campisi Hegan D; Sweasy JB; Glazer PM
    Cancer Res; 2010 Jan; 70(1):409-17. PubMed ID: 20028873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.
    Tentori L; Turriziani M; Franco D; Serafino A; Levati L; Roy R; Bonmassar E; Graziani G
    Leukemia; 1999 Jun; 13(6):901-9. PubMed ID: 10360379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide: mechanisms of action, repair and resistance.
    Zhang J; Stevens MF; Bradshaw TD
    Curr Mol Pharmacol; 2012 Jan; 5(1):102-14. PubMed ID: 22122467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity.
    Saville KM; Al-Rahahleh RQ; Siddiqui AH; Andrews ME; Roos WP; Koczor CA; Andrews JF; Hayat F; Migaud ME; Sobol RW
    DNA Repair (Amst); 2024 Aug; 140():103700. PubMed ID: 38897003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.
    Agnihotri S; Burrell K; Buczkowicz P; Remke M; Golbourn B; Chornenkyy Y; Gajadhar A; Fernandez NA; Clarke ID; Barszczyk MS; Pajovic S; Ternamian C; Head R; Sabha N; Sobol RW; Taylor MD; Rutka JT; Jones C; Dirks PB; Zadeh G; Hawkins C
    Cancer Discov; 2014 Oct; 4(10):1198-213. PubMed ID: 25100205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells.
    Jaiswal AS; Banerjee S; Panda H; Bulkin CD; Izumi T; Sarkar FH; Ostrov DA; Narayan S
    Mol Cancer Res; 2009 Dec; 7(12):1973-83. PubMed ID: 19996303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methylpurine DNA glycosylase inhibits p53-mediated cell cycle arrest and coordinates with p53 to determine sensitivity to alkylating agents.
    Song S; Xing G; Yuan L; Wang J; Wang S; Yin Y; Tian C; He F; Zhang L
    Cell Res; 2012 Aug; 22(8):1285-303. PubMed ID: 22801474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
    Fishel ML; He Y; Smith ML; Kelley MR
    Clin Cancer Res; 2007 Jan; 13(1):260-7. PubMed ID: 17200364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses.
    Sobol RW; Kartalou M; Almeida KH; Joyce DF; Engelward BP; Horton JK; Prasad R; Samson LD; Wilson SH
    J Biol Chem; 2003 Oct; 278(41):39951-9. PubMed ID: 12882965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
    Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
    Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells.
    Tentori L; Portarena I; Torino F; Scerrati M; Navarra P; Graziani G
    Glia; 2002 Oct; 40(1):44-54. PubMed ID: 12237842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial transcription factor A (TFAM) has 5'-deoxyribose phosphate lyase activity in vitro.
    Zhao W; Hussen AS; Freudenthal BD; Suo Z; Zhao L
    DNA Repair (Amst); 2024 May; 137():103666. PubMed ID: 38492429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkylation sensitivity screens reveal a conserved cross-species functionome.
    Svilar D; Dyavaiah M; Brown AR; Tang JB; Li J; McDonald PR; Shun TY; Braganza A; Wang XH; Maniar S; St Croix CM; Lazo JS; Pollack IF; Begley TJ; Sobol RW
    Mol Cancer Res; 2012 Dec; 10(12):1580-96. PubMed ID: 23038810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.
    Jaiswal AS; Banerjee S; Aneja R; Sarkar FH; Ostrov DA; Narayan S
    PLoS One; 2011 Feb; 6(2):e16691. PubMed ID: 21311763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells.
    Jaiswal AS; Panda H; Law BK; Sharma J; Jani J; Hromas R; Narayan S
    PLoS One; 2015; 10(5):e0123808. PubMed ID: 25933036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.